Should dialysis be stopped for an unrepresented patient with metastatic cancer?

Adira Hulkower, Sarah Garijo-Garde, Lauren S. Flicker

Research output: Contribution to journalArticle

Abstract

Unrepresented patients (also referred to as unbefriended, patients alone, patients without proxy, or isolated patients) are among the most vulnerable persons entering the health care system. Legislation concerning these patients varies across the United States, resulting in disparities in care. For example, the statutory definition of who is unrepresented varies. In some states, clergy or close friends may act as surrogates; in other states, they cannot do so. Available end-of-life options also differ, creating significant disparities in end-of-life care for these patients.

Original languageEnglish (US)
Pages (from-to)575-581
Number of pages7
JournalAMA Journal of Ethics
Volume21
Issue number7
DOIs
StatePublished - Jul 1 2019

Fingerprint

chronic illness
Dialysis
cancer
clergy
Neoplasms
legislation
health care
human being
Clergy
Terminal Care
Proxy
Legislation
Delivery of Health Care

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health(social science)
  • Health Policy

Cite this

Should dialysis be stopped for an unrepresented patient with metastatic cancer? / Hulkower, Adira; Garijo-Garde, Sarah; Flicker, Lauren S.

In: AMA Journal of Ethics, Vol. 21, No. 7, 01.07.2019, p. 575-581.

Research output: Contribution to journalArticle

Hulkower, Adira ; Garijo-Garde, Sarah ; Flicker, Lauren S. / Should dialysis be stopped for an unrepresented patient with metastatic cancer?. In: AMA Journal of Ethics. 2019 ; Vol. 21, No. 7. pp. 575-581.
@article{3e148251f49142439c29e7c149d460eb,
title = "Should dialysis be stopped for an unrepresented patient with metastatic cancer?",
abstract = "Unrepresented patients (also referred to as unbefriended, patients alone, patients without proxy, or isolated patients) are among the most vulnerable persons entering the health care system. Legislation concerning these patients varies across the United States, resulting in disparities in care. For example, the statutory definition of who is unrepresented varies. In some states, clergy or close friends may act as surrogates; in other states, they cannot do so. Available end-of-life options also differ, creating significant disparities in end-of-life care for these patients.",
author = "Adira Hulkower and Sarah Garijo-Garde and Flicker, {Lauren S.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1001/amajethics.2019.575",
language = "English (US)",
volume = "21",
pages = "575--581",
journal = "AMA journal of ethics",
issn = "2376-6980",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Should dialysis be stopped for an unrepresented patient with metastatic cancer?

AU - Hulkower, Adira

AU - Garijo-Garde, Sarah

AU - Flicker, Lauren S.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Unrepresented patients (also referred to as unbefriended, patients alone, patients without proxy, or isolated patients) are among the most vulnerable persons entering the health care system. Legislation concerning these patients varies across the United States, resulting in disparities in care. For example, the statutory definition of who is unrepresented varies. In some states, clergy or close friends may act as surrogates; in other states, they cannot do so. Available end-of-life options also differ, creating significant disparities in end-of-life care for these patients.

AB - Unrepresented patients (also referred to as unbefriended, patients alone, patients without proxy, or isolated patients) are among the most vulnerable persons entering the health care system. Legislation concerning these patients varies across the United States, resulting in disparities in care. For example, the statutory definition of who is unrepresented varies. In some states, clergy or close friends may act as surrogates; in other states, they cannot do so. Available end-of-life options also differ, creating significant disparities in end-of-life care for these patients.

UR - http://www.scopus.com/inward/record.url?scp=85068876794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068876794&partnerID=8YFLogxK

U2 - 10.1001/amajethics.2019.575

DO - 10.1001/amajethics.2019.575

M3 - Article

AN - SCOPUS:85068876794

VL - 21

SP - 575

EP - 581

JO - AMA journal of ethics

JF - AMA journal of ethics

SN - 2376-6980

IS - 7

ER -